JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guo, J.
Right arrow Articles by Yamamoto, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guo, J.
Right arrow Articles by Yamamoto, I.
Journal of Nuclear Medicine Vol. 45 No. 8 1334-1339
© 2004 by Society of Nuclear Medicine


Clinical Investigations

In Vitro Proton Magnetic Resonance Spectroscopic Lactate and Choline Measurements, 18F-FDG Uptake, and Prognosis in Patients with Lung Adenocarcinoma

JianFei Guo, MD1, Kotaro Higashi, MD1, Hajime Yokota, MD1, Yosinobu Nagao, PhD2,3, Yoshimichi Ueda, MD4, Yuko Kodama, MD1, Manabu Oguchi, MD1, Suzuka Taki, MD1, Hisao Tonami, MD1 and Itaru Yamamoto, MD1

1 Department of Radiology, Kanazawa Medical University, Ishikawa, Japan
2 Division of Advanced Medicine, Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan
3 Department of Biochemistry, Kanazawa Medical University, Ishikawa, Japan
4 Department of Pathology, Kanazawa Medical University, Ishikawa, Japan

It has been reported that 18F-FDG uptake, lactate concentration, and choline concentration are good indicators of malignant grade in several different kinds of tumors. In this study, we investigated the correlation between 18F-FDG uptake in 18F-FDG PET imaging, lactate concentration and choline concentration measured by in vitro 1H magnetic resonance spectroscopy (MRS), and survival probabilities in human lung adenocarcinoma. Methods: Nineteen patients with lung adenocarcinoma underwent 18F-FDG PET before surgery. The 1H MRS spectra were obtained in vitro from methanol–chloroform–water extracts of lung adenocarcinomas and normal lungs. The ratios of the lactate (Rlac) or choline (Rcho) concentration of lung adenocarcinoma to normal lung from the same patient were correlated with the mean standardized uptake value (SUV). The Kaplan–Meier life table method was used to analyze the relationship between 18F-FDG uptake, Rlac, Rcho, and patient survival probabilities. Results: There was no significant correlation between mean SUV and Rlac or Rcho in patients with lung adenocarcinoma. An SUV > 5 means poorer survival probabilities in patients with lung adenocarcinoma (P = 0.004). A higher Rlac probably indicates a trend for patients with lung adenocarcinoma to have poorer survival probabilities; however, Rcho is not an indicator of survival probability. 18F-FDG uptake significantly correlated with cell differentiation (P = 0.007), whereas Rlac and Rcho had no correlation with it. Conclusion: No significant correlation was found between SUV and Rlac or Rcho in patients with lung adenocarcinoma. Compared with Rlac and Rcho measured by in vitro MRS, 18F-FDG uptake is a better indicator of prognosis in patients with lung adenocarcinoma.

Key Words: 18F-FDG • lung adenocarcinoma • magnetic resonance spectroscopy • lactate • choline • prognosis


Related articles in JNM:

THIS MONTH IN JNM

JNM 2004 45: 8A-9A. [Full Text]  



This article has been cited by other articles:


Home page
JNMHome page
J. Guo, K. Higashi, Y. Ueda, M. Oguchi, T. Takegami, H. Toga, T. Sakuma, H. Yokota, S. Katsuda, H. Tonami, et al.
Microvessel Density: Correlation with 18F-FDG Uptake and Prognostic Impact in Lung Adenocarcinomas
J. Nucl. Med., March 1, 2006; 47(3): 419 - 425.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. K. Buck, G. Glatting, and S. N. Reske
Quantification of 18F-FDG Uptake in Non-Small Cell Lung Cancer: A Feasible Prognostic Marker?
J. Nucl. Med., August 1, 2004; 45(8): 1274 - 1276.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.